Please assess the completion status of the following clinical trial:

Trial Title: Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Metastatic soft tissue or bone sarcoma~* 18 years of age or older~* Adequate blood counts~* Adequate kidney and liver function~* At least 1 but no more than 3 prior systemic therapy regimens for this cancer~* Good performance status - able to carry out work of a light or sedentary nature~Exclusion Criteria:~* Pre-existing hear disease such as congestive heart failure, or arrhythmia known to increase the risk of thromboembolic events (blood clots)~* Blood clot in the last 6 months, known clotting problem or platelet disorder~* History of brain cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 82 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).